Pharma Documentation Ring (P-D-R) Direction and what we are trying to accomplish SLA PHTL Spring Meeting 11-13. April 2010 & Henning P. Nielsen what does it mean to you? 1958 P-D-R = “Pharma Dokumentation Ring” was founded by five companies in Germany: Bayer, Ciba (Novartis), Knoll (Abbott), Merck, Thomae (Boehringer Ingelheim) Join forces to index scientific biomedical literature Agenda: • • • • • • • What is P-D-R? Who are we? How are we working? What has been/are our main focus areas? What have we achieved? Impact on you? Why is it working so well? What is P-D-R? (P-D-R Scope and Guidelines: ) The association, which bears the name: "Pharma Documentation Ring" (P‐D‐R) is a corporate‐based non‐profit making organization. Member organisations: • Member organisations should be research-based pharmaceutical, biotech, or chemical companies having a research-based pharmaceutical division or subsidiary • Membership is corporate‐based. • A corporate group is represented by a single membership of the P‐D‐R, affiliated or subsidiary companies being covered by this membership. • One rep per company – second rep may be accepted depending on structure What’s the costs? • Membership fees are not exacted. !! • Members must, however, commit to make a positive contribution to the work of the P-D-R by actively participating in meetings, working groups, as well as acting as a coordinator of a PD-R topic. • Members must also commit to host an AGM on a rota basis. Who are we? P-D-R : 24 corporate members from EU, US, AUS, and J Wyeth ABBOTT ASTRAZENECA UCB BASF TAKEDA BAYER HEALTHCARE SOLVAY SCHERING-PLOUGH BOEHRINGER INGELHEIM SANOFI AVENTIS PFIZER BRISTOL-MYERS SQUIBB NYCOMED CSL BEHRING NOVO NORDISK ELI LILLY NOVARTIS FERRING MERCK & CO GILEAD MERCK KGaA GLAXOSMITHKLINE HOFFMANNLA ROCHE Status: January 2010 How do we work ? Aims Promote exchange of experience and networking among members Jointly assess new and existing products and services Provide a forum for the information industry Encourage commercial development of new information services and systems How do we work? The organs of the association: – P-D-R Executive Board – Meeting of the members AGM – Topic Group Teams – Ad hoc task force groups – Special Meetings P-D-R Executive Board Claudia Körner - Bayer HealthCare Lou Ann Di Nallo - BMS Matthias Staab – Sanofi-Aventis Henning Nielsen - Novo Nordisk • Elected at the AGM for 2 years • Prepares and runs the AGM together with host company • Selects strategic topics • Allocates members to topic groups • Initiates special meetings • Adapts scope and guidelines to the needs • First contact for providers and potential new members • And all the other things: coaching, pushing, firefighting, etc… AGMs • Host company on a rotating basis • Attended by all member companies • • • • Company reports Topic sessions 1-2 strategic sessions Contact with other organizations Topic Groups: • Each representative assigned to a topic • Topic co-ordinator appointed • Topics regularly reviewed for appropriateness - is this still a hot topic? • Presentations to AGM summing up the main events in that topic area – guest speakers – survey results Current Topic Groups • Biomedical Information • Business Information • Chemical Information and Patents • Information and Knowledge Management • Library Affairs and Copyright • Technology & Intranet/Internet • P-D-R News & Website Ad-Hoc Task Forces & Special meetings – examples • • • • • • • • • • • • • Inter/intranet -1997 Electronic journal licensing - 1998 Knowledge management - 1999 Linking – 2000 Biotechnology Information & Intellectual Property - 2002 Taxonomy & Text mining 2003 Taskforce on e-journals 2004 P-D-R / SSP meeting 2006 3rd party usage – 2006 Copyright 2005/06 PDR/STM on use of publications - 2008 Marketing use of publications – 2009 … P-D-R surveys • 28 surveys in 2009 • big and small • only respondents receive the consolidated, anonymised report • many leading to AGM reports 08/04/2015 18 Main focus areas: • Building a global network of information management groups within the pharmaceutical sector – and creating the atmosphere of sharing and exchange of ideas • Establishing P-D-R as a known association and player in the information world & creating an understanding of the special needs of the pharma industry Main focus areas: • Partnering with the information industry: – Creating new model licenses and guidelines – Involving P-D-R members in advisory boards – Involving P-D-R in experiments and developments of new tools and technologies • Partnering with other information groups - as today Achievements Promote exchange of experience and networking among members • Concurrent benchmarking • Small member group with the necessary confidence to respect the openness and confidentiality of our discussions Achievements Jointly assess new and existing products and services •Meetings with stakeholders, publishers, suppliers •Collectively addressing suppliers with problems and possible solutions •Surveys Achievements Provide a forum for the information industry • Memberships of advisory boards • Presenting at meetings, conferences,… • Attendance to our special meetings • Speak with one voice Encourage commercial development of new information services and systems • Ringdoc = Derwent Drug File • Actively partner with suppliers in enhancement and development of systems • Textmining / ontology experimental task forces Journal licensing and usage rights 12 years of partnering with publishers and their associations. • P-D-R Spring Meeting On Electronic Journals May 1998 • P-D-R STM/ALPSP task force on e-journal licensing 19982000 / Draft Model Licence • P-D-R Proposal for Quality Standards of Electronic STM Journals. 2004 • Pharmaceutical Industry/Publishers’ Working Group Guidelines for External Distribution of E-Content. 2004 Journal licensing and usage rights 12 years of partnering with publishers and their associations. • PDR SSP meeting in Baltimore June 2006 • P-D-R Task Force on copyright 2006-2007: New Model Licence for Publications in the Pharmaceutical Industry. 2007 • P-D-R stakeholder meeting in Montpellier on scholarly publishing and pharma needs. February 2008. • PDR/STM stakeholder meeting in Reims on marketing usage of scholarly publications. March 2009. • Planning started on follow-up in 2011 What is the impact on you? • Understanding of your needs among stakeholders • Impact on information resources and developments • Better licensing terms • … Better licensing terms: • • • • • • • • • Model license Definition of authorised users Regulatory and patent litigation usage Training purposes Project storage Medical information (unsolicited) Scientific advisors Scolarly sharing Contractors And we are working on identifying the gaps: – – – – – Outsourcing Marketing usage Translations Our own content Business models for marketing usage – Meeting 2011 (?) Why is it working so well? • Willingness to share - give and take within the bounds of confidentiality and competitive advantage • Commitment makes things happen • The best benchmarking tool we have • Relatively small meetings - easy to network • The partnership approach to stakeholders P-D-R in the last 15 years • Shaped in the 90’s and matured in the new millennium •23 companies working together on learning, sharing, and impacting the information and knowledge environment in the pharmaceutical industry Partnering with the information industry to innovate, develop, and promote the data and tools needed for our corporate strategies Being innovative in our use of new technologies Being ready for changes affecting our contributions to our corporate strategies •Probably a rather unique association in a competitive world!! And it is also a lot of fun! Thank you for your attention! Any questions? References: • Website: www.p-d-r.com • Publications: www.p-d-r.com/publications/publications.html • Latest article: Henning P.Nielsen and Sven-Olaf Vogt • What pharmaceutical libraries really want. • Learned Publishing. Vol.23 No.1 January 2010. 53-58.